CrushSCI.com
Journal Selection & Manuscript Polishing Services
Frontiers in Oncology 临时占位封面 Medicine
Back to journal directory

Review Cycle Records

Frontiers in Oncology

Frontiers SCIE OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
108.9Average days
89Median days
15Fastest days
280Longest days
4,5762025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

15 days

Gut microbiota-mediated chemotherapy resistance in colorectal cancer: mechanisms and precision interventions

AuthorsYan Li; Fangrui Wang; Tao Li; Ying Liu

Affiliations1. School of Medicine, Medical College, Wuhan University of Science and Technology, China; 2. Department of Laboratory Medicine, General Hospital of Central Theater Command, China; 3. Hubei Key Laboratory of Central Nervous System Tumors and Intervention, China

Source PDF DOI Publisher page
48 days

Pre-radiotherapy cachexia is associated with treatment discontinuation in patients with head and neck squamous cell carcinoma receiving definitive radiotherapy

AuthorsQianrong Guo; Yan Sun; Yue Ni; Wenting Li; Lixin Wang; Minlei Zhu; Mianhua Wu

Affiliations1. First Clinical Medical College, Nanjing University of Chinese Medicine, China; 2. Changzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, China; 3. Jiangsu Province Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, China

Source PDF DOI Publisher page
70 days

Prehabilitation for patients undergoing neoadjuvant treatment: results of a single-center pilot study using an integrative medicine day clinic

AuthorsSvenja Klaus-Karwisch; Stephanie Otto; Paul Georg Werthmann; Ann-Kathrin Lederer; André Leopold Mihaljevic; Fynn Treiber; Lena Cihlar; Keanu Leins; Benjamin Mayer; Klaus Kramer

Affiliations1. Section Integrative Medicine, Department of General and Visceral Surgery, Ulm University Medical Center, Ulm University, Germany; 2. Comprehensive Cancer Center Ulm (CCCU), Ulm University Hospital, Germany; 3. Department of Gynaecology and Obstetrics, Ulm University Hospital, Germany; 4. Department of Internal Medicine I, Ulm University Hospital, Germany; 5. Department of Internal Medicine III, Ulm University Hospital, Germany; 6. Fascia Research Society (FRS), United States; 7. Department of General, Visceral and Transplantation Surgery, University Hospital Tuebingen, Germany; 8. Institute of Epidemiology and Medical Biometry, University Ulm, Germany; 9. University Ulm, Germany

Source PDF DOI Publisher page
82 days

Artificial intelligence in colorectal cancer multidisciplinary decision-making: concordance, predictive support and clinical translation

AuthorsAristotelis Nikitaras; Sandra Maria Tsoti; Manousos-Georgios Pramateftakis

Affiliations1. Athens Euroclinic, Greece; 2. Saint Savvas General Anticancer-Oncology Hospital of Athens, Greece; 3. Aristotle University of Thessaloniki, Greece

Source PDF DOI Publisher page
87 days

Age-stratified prevalence of colorectal adenoma and advanced neoplasia in adults aged 18–39 years: a single-center cross-sectional study of 2, 149 colonoscopies

AuthorsYiming Ding; Jiani Liu; Huihui Li; Xiangchun Lin

Affiliations1. Department of Gastroenterology, Peking University International Hospital, China

Source PDF DOI Publisher page
91 days

PIWIL4: from biological characteristics to disease pathogenesis and clinical applications

AuthorsQi Deng; Yi Liu; Yang Qu; YanQiong Yu; YuMing Liu; QiBing Yan; YongKang Wu

Affiliations1. West China Hospital, Sichuan University Jintang Hospital. Jintang First People’s Hospital, China; 2. West China Hospital, Sichuan University, China

Source PDF DOI Publisher page
95 days

The “ADC-after-ADC” paradigm: navigating cross-resistance and sequencing in breast cancer therapy

AuthorsMichael Asare; Trinitas Oserefuamen Okobi; Susan Karass; Joseph Tobechukwu Okobi; Evelyn Taiwo

Affiliations1. Department of Medicine, BronxCare Health System, United States; 2. Division of Hematology and Medical Oncology, NewYork-Presbyterian Brooklyn Methodist Hospital, United States

Source PDF DOI Publisher page
126 days

Secretory carrier membrane protein 3 modulates nuclear ERK1/2 signaling and drug response in triple-negative breast cancer

AuthorsBeatriz M. Morales-Cabán; Millenia Jackson-González; Fernando A. Acosta-Pérez; Bryan S. Ortiz-Torres; Ivette J. Suárez-Arroyo

Affiliations1. Department of Biochemistry, School of Medicine, Universidad Central del Caribe, United States; 2. Department of Industrial and Systems Engineering, University of Wisconsin-, United States

Source PDF DOI Publisher page
147 days

Neurophysiological monitoring of cranial nerves III and VI in endoscopic skull base surgery: scoping review and comparative study

AuthorsSimona Serioli; Ginevra D’Onofrio; Federico Valeri; Alberto Pietrantoni; Laura Broglio; Ludovico Agostini; Pier Paolo Mattogno; Vito Stifano; Marco Maria Fontanella; Liverana Lauretti; Mario Rigante; Davide Mattavelli; Marco Ferrari; Jacopo Galli; Alessandro Olivi; Michele di Domenico; Francesco Doglietto

Affiliations1. Department of Neurosurgery, Papa Giovanni XXIII Hospital, Italy; 2. Technology for Health PhD Program, University of Brescia, Italy; 3. Neurosurgery, Department of Neurosciences, Università Cattolica del Sacro Cuore, Italy; 4. Neurosurgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy; 5. Department of Pathology, Spedali Civili of Brescia, University of Brescia, Italy; 6. Department of Neurology, Spedali Civili of Brescia, University of Brescia, Italy; 7. Division of Neurosurgery, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Spedali Civili of Brescia, University of Brescia, Italy; 8. Department of ENT, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy; 9. Unit of Otorhinolaryngology, Head and Neck Surgery, Department of Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy; 10. Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neuroscience, University of Padova, Italy; 11. Unit of Otorhinolaryngology-Head and Neck Surgery, Padua University Hospital, Italy

Source PDF DOI Publisher page
280 days

Trastuzumab deruxtecan in HER2-positive metastatic breast cancer with severe hepatic dysfunction: a case report and narrative literature review

AuthorsGiuseppe Saltalamacchia; Riccardo Gerosa; Jacopo Canzian; Chiara Benvenuti; Caterina Giannitto; Flavia Jacobs; Mariangela Gaudio; Benedetta Tinterri; Chiara Miggiano; Giovanna Masci; Rita De Sanctis; Rosalba Torrisi; Armando Santoro

Affiliations1. Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Italy; 2. Department of Biomedical Sciences, Humanitas University, Italy

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.